Douglas Adamson

3.0k total citations
40 papers, 853 citations indexed

About

Douglas Adamson is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Douglas Adamson has authored 40 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Douglas Adamson's work include Reproductive Biology and Fertility (4 papers), Esophageal Cancer Research and Treatment (4 papers) and Management of metastatic bone disease (4 papers). Douglas Adamson is often cited by papers focused on Reproductive Biology and Fertility (4 papers), Esophageal Cancer Research and Treatment (4 papers) and Management of metastatic bone disease (4 papers). Douglas Adamson collaborates with scholars based in United Kingdom, Spain and Sweden. Douglas Adamson's co-authors include Robert Leonard, Derek J. King, Neva E. Haites, Gibin Powathil, Mark A. J. Chaplain, Gianfilippo Bertelli, Colin A. Purdie, Roger Tatoud, C. Roland Wolf and Janine Mansi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Douglas Adamson

38 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Adamson United Kingdom 16 276 201 190 179 170 40 853
Pauline de Graeff Netherlands 17 262 0.9× 109 0.5× 73 0.4× 138 0.8× 119 0.7× 36 763
Peggy Wan United States 15 377 1.4× 106 0.5× 199 1.0× 140 0.8× 117 0.7× 22 971
Enora Laas France 21 585 2.1× 107 0.5× 181 1.0× 350 2.0× 228 1.3× 97 1.5k
M Soukop United Kingdom 19 575 2.1× 81 0.4× 215 1.1× 111 0.6× 188 1.1× 48 1.1k
Shelly Cummings United States 20 431 1.6× 197 1.0× 64 0.3× 374 2.1× 183 1.1× 42 1.6k
Leslie R. Boyd United States 19 243 0.9× 80 0.4× 298 1.6× 61 0.3× 306 1.8× 60 949
Keith Y. Terada United States 19 243 0.9× 80 0.4× 232 1.2× 157 0.9× 530 3.1× 50 1.3k
Seraina Schmid Switzerland 16 342 1.2× 69 0.3× 153 0.8× 419 2.3× 71 0.4× 48 972
Anne T. Mancino United States 14 281 1.0× 77 0.4× 347 1.8× 252 1.4× 46 0.3× 34 1.1k
K.-D. Schulz Germany 15 160 0.6× 75 0.4× 75 0.4× 111 0.6× 169 1.0× 31 634

Countries citing papers authored by Douglas Adamson

Since Specialization
Citations

This map shows the geographic impact of Douglas Adamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Adamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Adamson more than expected).

Fields of papers citing papers by Douglas Adamson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Adamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Adamson. The network helps show where Douglas Adamson may publish in the future.

Co-authorship network of co-authors of Douglas Adamson

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Adamson. A scholar is included among the top collaborators of Douglas Adamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Adamson. Douglas Adamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Downie, Samantha, et al.. (2022). Mirels’ score for upper limb metastatic lesions: do we need a different cutoff for recommending prophylactic fixation?. JSES International. 6(4). 675–681. 7 indexed citations
2.
Adamson, Douglas, Jane Blazeby, Chris Hurt, et al.. (2021). Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT. Health Technology Assessment. 25(31). 1–144. 3 indexed citations
3.
Adamson, Douglas, Anthony Byrne, Jane Blazeby, et al.. (2021). Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial. ˜The œLancet. Gastroenterology & hepatology. 6(4). 292–303. 26 indexed citations
4.
Vinnicombe, Sarah, et al.. (2019). Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer. Cancer Imaging. 19(1). 91–91. 15 indexed citations
5.
Anderson, Richard A., et al.. (2017). The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer. European Journal of Cancer. 87. 58–64. 57 indexed citations
6.
Leonard, Robert, Douglas Adamson, Gianfilippo Bertelli, et al.. (2017). GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial. Annals of Oncology. 28(8). 1811–1816. 108 indexed citations
7.
Wilson, Caroline, Fatma Gossiel, Robert Leonard, et al.. (2016). Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover. Journal of bone oncology. 5(1). 43–49. 4 indexed citations
8.
Coombs, Nathan, Julian M. Singer, Max Bulsara, et al.. (2016). Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT. BMJ Open. 6(5). e010703–e010703. 60 indexed citations
9.
Fallon, Marie, Peter Hoskin, Lesley Colvin, et al.. (2015). Randomized Double-Blind Trial of Pregabalin Versus Placebo in Conjunction With Palliative Radiotherapy for Cancer-Induced Bone Pain. Journal of Clinical Oncology. 34(6). 550–556. 48 indexed citations
10.
Bryant, Peter E., et al.. (2012). Topoisomerase II  levels and G2 radiosensitivity in T-lymphocytes of women presenting with breast cancer. Mutagenesis. 27(6). 737–741. 3 indexed citations
11.
Lassen, Ulrik, Wilson H. Miller, Sébastien J. Hotte, et al.. (2012). Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours. Cancer Chemotherapy and Pharmacology. 71(2). 543–549. 7 indexed citations
12.
Adamson, Douglas, et al.. (2008). The fifth cause of splenomegaly?-parvovirus B19. Clinical & Laboratory Haematology. 14(4). 327–330.
13.
Adamson, Douglas, et al.. (2008). Reversible infertility and Castleman's disease. Clinical & Laboratory Haematology. 13(4). 349–350.
14.
Adamson, Douglas, et al.. (2007). CA 19-9 and Survival in Advanced and Unresectable Pancreatic Adenocarcinoma and Cholangiocarcinoma. Journal of Gastrointestinal Cancer. 38(2-4). 108–114. 17 indexed citations
15.
Adamson, Douglas, et al.. (2002). Diclofenac Antagonizes Peroxisome Proliferator-Activated Receptor-γ Signaling. Molecular Pharmacology. 61(1). 7–12. 68 indexed citations
16.
Adamson, Douglas, et al.. (2002). Fluorescence-based ligand-binding assays for peroxisome proliferator-activated receptors. Methods in enzymology on CD-ROM/Methods in enzymology. 357. 188–197. 3 indexed citations
17.
Adamson, Douglas, et al.. (1993). OCCULT MALIGNANCY IS ASSOCIATED WITH VENOUS THROMBOSIS UNRESPONSIVE TO ADEQUATE ANTICOAGULATION. International Journal of Clinical Practice. 47(4). 190–191. 2 indexed citations
18.
Adamson, Douglas, Derek J. King, & Neva E. Haites. (1992). Significant telomere shortening in childhood leukemia. Cancer Genetics and Cytogenetics. 61(2). 204–206. 63 indexed citations
19.
Adamson, Douglas & Patricia M. Gordon. (1992). Hemiplegia - A Rare Complication of Acute Epstein-Barr Virus (EBV) Infection. Scandinavian Journal of Infectious Diseases. 24(3). 379–380. 1 indexed citations
20.
Adamson, Douglas, et al.. (1976). Dominant Inheritance Diabetes Mellitus. Journal of the Royal College of Physicians of London. 11(1). 86–90. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pauline de Graeff Breakdown of academic impact, for papers by Peggy Wan Breakdown of academic impact, for papers by Enora Laas Breakdown of academic impact, for papers by M Soukop Breakdown of academic impact, for papers by Shelly Cummings Breakdown of academic impact, for papers by Leslie R. Boyd Breakdown of academic impact, for papers by Keith Y. Terada Breakdown of academic impact, for papers by Seraina Schmid Breakdown of academic impact, for papers by Anne T. Mancino Breakdown of academic impact, for papers by K.-D. Schulz
Rankless by CCL
2026